摘要
                
                    流感及目前仍在流行的新型冠状病毒肺炎属于中医疫病范畴,中医防控疫病历史悠久、方法多样,雄黄是古代预防疫病最常用的药物。文章通过进一步分析古今文献,对雄黄的临床应用范围、毒性认识以及在疫病中的使用情况等进行系统梳理。雄黄在古代疫病防治中应用广泛,在现代也显示出一定潜力,有希望作为传染病防治的矿物药代表进行再次研发。且雄黄防治疫病使用方法多样,可丰富传染病防控方法与剂型。希望在未来可作为安全、有效的药物为防治疫病提供更多选择与保障。
                
                Influenza and the currently prevalent Corona Virus Disease 2019 belong to the category of infectious disease in traditional Chinese medicine. Traditional Chinese medicine has a long history of preventing and controlling epidemics and has various methods. Realgar(Xionghuang) was the most commonly used drug for preventing epidemics in ancient times. By further analyzing ancient and modern literature, this paper systematically sorts out the clinical application range of Realgar, understanding of toxicity and use in infectious diseases. Realgar was widely used in the prevention and control of infectious diseases in ancient times,and it also shows certain potential in modern times. In addition, Realgar can be used in various ways to prevent and control diseases,which can enrich the methods and formulations of infectious disease prevention and control. It is hoped that in the future, it can be used as a safe and effective drug to provide more choices and guarantees for the prevention and treatment of infectious diseases.
    
    
                作者
                    郝鸣昭
                    黎晓蕾
                    张悦
                    董毅智
                    李皓月
                    赵静
                HAO Ming-zhao;LI Xiao-lei;ZHANG Yue;DONG Yi-zhi;LI Hao-yue;ZHAO Jing(Institute of History of Medicine and Medical Literature,China Academy of Chinese Medical Sciences,Beijing 100700,China;Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;International Cooperation Department,China Academy of Chinese Medical Sciences,Beijing 100700,China)
     
    
    
                出处
                
                    《中华中医药杂志》
                        
                                CAS
                                CSCD
                                北大核心
                        
                    
                        2022年第7期3696-3699,共4页
                    
                
                    China Journal of Traditional Chinese Medicine and Pharmacy
     
            
                基金
                    中国中医科学院科技创新工程项目(No.CI2021A00704-4)
                    中国中医科学院科技创新工程中医临床基础学科创新团队项目(No.CI2021B003)。
            
    
                关键词
                    雄黄
                    疫病
                    防治
                    药物研发
                    外用
                
                        Realgar(Xionghuang)
                        Infectious disease
                        Prevention and treatment
                        Drug development
                        External application
                
     
    
    
                作者简介
通信作者:赵静,北京市东城区东直门内南小街16号中国中医科学院中医临床基础研究所,邮编:100700,电话:010-84015484,E-mail:hhzhaojing@126.com。